[ET Net News Agency, 27 January 2026] INNOGEN-B (02591) rose 51.2% to HK$46.14.
It hits an intra-day high of HK$46.1, hitting an 1-month high, breaking above the 100-D SMA of HK$35.854, and an intra-day low of HK$30.64. The total shares traded was 354,200, with a value of HK$12.94m. The active buy/sell ratio is 60:40, with net buying turnover of HK$2.38m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$1.15m, with volume weighted average price of HK$34.98. FUTU SEC INT'L accounts for greatest net responsive selling turnover of HK$1.44m, with volume weighted average price of HK$39.073.
Basic Information| Nominal | 46.140 | % Chg | +51.18% |
| High | 46.100 | Low | 30.640 |
| Shares Tr | 354,200 | Turnover | 12.94m |
| 10-D SMA | 32.528 | %H.V | 26.998 |
| 20-D SMA | 31.808 | VWAP | 36.540 |
| 50-D SMA | 34.078 | RSI14 | 78.113 |
Status: Breaking above the 100-D SMA, hitting an 1-month high, active buy/sell ratio is 60:40, with net buying turnover of HK$2.38m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 46.14 | +51.18 |
| INNOVENT BIO (01801) | 80.65 | -1.22 |
| XTALPI (02228) | 12.60 | -0.24 |
| WUXI XDC (02268) | 65.10 | -1.74 |
| WUXI BIO (02269) | 37.46 | -1.99 |
| WUXI APPTEC (02359) | 113.20 | -0.88 |
| BEONE MEDICINES (06160) | 200.60 | -0.69 |
| CANSINOBIO (06185) | 37.38 | -6.27 |
| BOAN BIOTECH (06955) | 8.71 | +0.58 |
| AKESO (09926) | 111.00 | -0.98 |
(ed)
Nominal 